Patents

US 12735488 B2: Antibodies binding to vista at acidic pH

Granted
2026-09-15
Filed
2020-09-18 application 17761458
Type
Utility · 23 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present application relates to antibodies specifically binding to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH and their use in cancer treatment. In some embodiments, the antibodies bind specifically to human VISTA at acidic pH, but do not significantly bind to human VISTA at neutral or physiological pH.

Source: PTBLXML, file of 2026-09-15 (ipgb20260915.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Bristol-Myers Squibb Company 1,812 patentsUS company or organizationPrinceton, NJBRISTOL MYERS SQUIBB CO SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPTBLXML, file of 2026-09-15

Inventors

InventorPlacePatentsPerson pageSource
Lin Hui SuSomerville, MA8PTBLXML, file of 2026-09-15
Sabrina MuellerMountain View, CAPTBLXML, file of 2026-09-15

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/2827PTBLXML, file of 2026-09-15
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PTBLXML, file of 2026-09-15
A61KPreparations for medical, dental or toiletry purposesA61K2039/505PTBLXML, file of 2026-09-15

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.